Does REBOXETINE Cause Obesity? 9 Reports in FDA Database

Q: Does REBOXETINE cause Obesity?

9 reports of Obesity have been filed with the FDA for REBOXETINE, representing 4.9% of all REBOXETINE adverse event reports.

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Obesity have been filed in association with REBOXETINE. This represents 4.9% of all adverse event reports for REBOXETINE.

Reports of Obesity with REBOXETINE

4.9%

of all REBOXETINE reports

Deaths

Hospitalizations

How Dangerous Is Obesity From REBOXETINE?

Of the 9 reports.

Is Obesity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for REBOXETINE. However, 9 reports have been filed with the FAERS database.

What Other Side Effects Does REBOXETINE Cause?

Hyperhidrosis (21) Off label use (20) Weight increased (18) Tachycardia (17) Confusional state (16) Intentional overdose (16) Nausea (16) Drug ineffective (15) Drug interaction (15) Sleep disorder (15)

What Other Drugs Cause Obesity?

RISPERIDONE (3,039) PREDNISONE (1,880) METHOTREXATE (1,876) ADALIMUMAB (1,780) TOCILIZUMAB (1,630) ABATACEPT (1,605) INFLIXIMAB (1,536) HYDROXYCHLOROQUINE (1,532) SULFASALAZINE (1,455) ETANERCEPT (1,407)

Which REBOXETINE Alternatives Have Lower Obesity Risk?

REBOXETINE vs RECLAST REBOXETINE vs RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E REBOXETINE vs REGADENOSON REBOXETINE vs REGORAFENIB REBOXETINE vs REGORAFENIB\REGORAFENIB

REBOXETINE Full Profile All Obesity Reports All Drugs Causing Obesity REBOXETINE Demographics